Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Testing the Tablet
Vienna -- Oral pimecrolimus is an effective and well-tolerated treatment for certain inflammatory skin diseases, such as chronic plaque psoriasis and atopic dermatitis, according to Klaus Wolff, M.D., F.R.C.P., professor of dermatology and chairman, department of dermatology, University of Vienna, Austria.
Related Videos
Related Content
